| human | Q5 |
| P2798 | Loop ID | 391178 |
| P496 | ORCID iD | 0000-0003-4704-3019 |
| P3829 | Publons author ID | 2897383 |
| P1053 | ResearcherID | A-1694-2008 |
| P1153 | Scopus author ID | 7005394797 |
| P734 | family name | Egea | Q37478928 |
| Egea | Q37478928 | ||
| Egea | Q37478928 | ||
| P735 | given name | Javier | Q1142232 |
| Javier | Q1142232 | ||
| P106 | occupation | researcher | Q1650915 |
| P21 | sex or gender | male | Q6581097 |
| Q37951070 | 1,8-Naphthyridine derivatives as cholinesterases inhibitors and cell Ca2+ regulators, a multitarget strategy for Alzheimer's disease |
| Q38195865 | A review of metal-catalyzed molecular damage: protection by melatonin |
| Q38969497 | Agmatine induces Nrf2 and protects against corticosterone effects in hippocampal neuronal cell line |
| Q38875865 | Agmatine, by Improving Neuroplasticity Markers and Inducing Nrf2, Prevents Corticosterone-Induced Depressive-Like Behavior in Mice |
| Q46694948 | Alpha7 nicotinic receptor activation protects against oxidative stress via heme-oxygenase I induction |
| Q88116246 | Analysis of gene expression profiles of CR80, a neuroprotective 1,8-Naphthyridine |
| Q38558848 | Anti-inflammatory role of microglial alpha7 nAChRs and its role in neuroprotection |
| Q37732930 | Antioxidant, antiinflammatory and neuroprotective actions of chondroitin sulfate and proteoglycans |
| Q39302882 | Benzothiazepine CGP37157 and its isosteric 2'-methyl analogue provide neuroprotection and block cell calcium entry |
| Q46985466 | Blockade of nicotinic receptors of bovine adrenal chromaffin cells by nanomolar concentrations of atropine |
| Q43184352 | Both creatine and its product phosphocreatine reduce oxidative stress and afford neuroprotection in an in vitro Parkinson's model |
| Q38831694 | CALHM1 and its polymorphism P86L differentially control Ca²⁺homeostasis, mitogen-activated protein kinase signaling, and cell vulnerability upon exposure to amyloid β. |
| Q41539324 | Calcium signalling mediated through α7 and non-α7 nAChR stimulation is differentially regulated in bovine chromaffin cells to induce catecholamine release |
| Q39459684 | Chemical and pharmacological studies on enantiomerically pure p-methoxytacripyrines, promising multi-target-directed ligands for the treatment of Alzheimer's disease |
| Q60462302 | Chondroitin sulfate reduces cell death of rat hippocampal slices subjected to oxygen and glucose deprivation by inhibiting p38, NFκB and iNOS. |
| Q46477382 | ConBr, A Lectin Purified from the Seeds of Canavalia brasiliensis, Protects Against Ischemia in Organotypic Culture of Rat Hippocampus: Potential Implication of Voltage-Gated Calcium Channels. |
| Q47376955 | Corrigendum to "European contribution to the study of ROS: A summary of the findings and prospects for the future from the COST action BM1203 (EU-ROS)" [Redox Biol. 13 (2017) 94-162]. |
| Q91606402 | Curcumin reduces renal damage associated with rhabdomyolysis by decreasing ferroptosis-mediated cell death |
| Q60688922 | Desensitized Nicotinic Receptors That, However, Afford Cytoprotection in Bovine Chromaffin Cells |
| Q91906967 | Early toll-like receptor 4 blockade reduces ROS and inflammation triggered by microglial pro-inflammatory phenotype in rodent and human brain ischaemia models |
| Q45368696 | Enantioselective neuroprotective effects of Tacripyrine ITH122 against oxygen and glucose deprivation in rat hippocampal slices |
| Q51998379 | Enhancement of secretion by threshold nicotinic stimulation in bovine chromaffin cells. |
| Q48289531 | Enzymatic and solid-phase synthesis of new donepezil-based L- and d-glutamic acid derivatives and their pharmacological evaluation in models related to Alzheimer's disease and cerebral ischemia |
| Q33761211 | European contribution to the study of ROS: A summary of the findings and prospects for the future from the COST action BM1203 (EU-ROS). |
| Q52726532 | Folic Acid Protects Against Glutamate-Induced Excitotoxicity in Hippocampal Slices Through a Mechanism that Implicates Inhibition of GSK-3β and iNOS. |
| Q64072607 | From single drug targets to synergistic network pharmacology in ischemic stroke |
| Q46488938 | Functional interference between glycogen synthase kinase-3 beta and the transcription factor Nrf2 in protection against kainate-induced hippocampal cell death |
| Q44971808 | Galantamine and memantine produce different degrees of neuroprotection in rat hippocampal slices subjected to oxygen-glucose deprivation |
| Q54549813 | Galantamine elicits neuroprotection by inhibiting iNOS, NADPH oxidase and ROS in hippocampal slices stressed with anoxia/reoxygenation. |
| Q50955863 | Guanosine controls inflammatory pathways to afford neuroprotection of hippocampal slices under oxygen and glucose deprivation conditions. |
| Q39334402 | Guanosine protects human neuroblastoma SH-SY5Y cells against mitochondrial oxidative stress by inducing heme oxigenase-1 via PI3K/Akt/GSK-3β pathway. |
| Q43297366 | Haeme oxygenase-1 overexpression via nAChRs and the transcription factor Nrf2 has antinociceptive effects in the formalin test |
| Q38227730 | ITH12410/SC058: a new neuroprotective compound with potential in the treatment of Alzheimer's disease |
| Q60689087 | Identification of 4,6-diaryl-1,4-dihydropyridines as a new class of neuroprotective agents |
| Q39075138 | Ischemic brain injury: New insights on the protective role of melatonin |
| Q38317383 | Lectin from Canavalia brasiliensis (ConBr) protects hippocampal slices against glutamate neurotoxicity in a manner dependent of PI3K/Akt pathway |
| Q104560418 | Melatonin Reduces NLRP3 Inflammasome Activation by Increasing α7 nAChR-Mediated Autophagic Flux |
| Q38684594 | Melatonin as a versatile molecule to design novel multitarget hybrids against neurodegeneration |
| Q46490330 | Melatonin protects against oxygen and glucose deprivation by decreasing extracellular glutamate and Nox-derived ROS in rat hippocampal slices |
| Q42107527 | Melatonin-sulforaphane hybrid ITH12674 induces neuroprotection in oxidative stress conditions by a 'drug-prodrug' mechanism of action |
| Q46718947 | Microglial HO-1 induction by curcumin provides antioxidant, antineuroinflammatory, and glioprotective effects |
| Q42936340 | Mitochondrial Na+/Ca2+ exchanger, a new target for neuroprotection in rat hippocampal slices |
| Q45976080 | Mitochondrial Na+/Ca2+-exchanger blocker CGP37157 protects against chromaffin cell death elicited by veratridine. |
| Q60689081 | Modulation of serine/threonine phosphatases by melatonin: therapeutic approaches in neurodegenerative diseases |
| Q59505514 | Multipotente Liganden mit kombinierter Cholinesterase- und Monoaminooxidase-Inhibition sowie Histamin-H3 R-Antagonismus bei neurodegenerativen Erkrankungen |
| Q48130975 | Multitarget-Directed Ligands Combining Cholinesterase and Monoamine Oxidase Inhibition with Histamine H3 R Antagonism for Neurodegenerative Diseases. |
| Q33850729 | N-acylaminophenothiazines: neuroprotective agents displaying multifunctional activities for a potential treatment of Alzheimer's disease |
| Q42503323 | NOX4-dependent neuronal autotoxicity and BBB breakdown explain the superior sensitivity of the brain to ischemic damage. |
| Q46114392 | NP04634 prevents cell damage caused by calcium overload and mitochondrial disruption in bovine chromaffin cells |
| Q98164577 | Na+ controls hypoxic signalling by the mitochondrial respiratory chain |
| Q46912355 | Neuroprotectant minocycline depresses glutamatergic neurotransmission and Ca(2+) signalling in hippocampal neurons. |
| Q28591328 | Neuroprotection afforded by nicotine against oxygen and glucose deprivation in hippocampal slices is lost in alpha7 nicotinic receptor knockout mice |
| Q48326424 | Neuroprotection by nicotine in hippocampal slices subjected to oxygen-glucose deprivation: involvement of the alpha7 nAChR subtype |
| Q46922338 | Neuroprotective effect of dimebon against ischemic neuronal damage |
| Q54581993 | Neuroprotective effect of guanosine against glutamate-induced cell death in rat hippocampal slices is mediated by the phosphatidylinositol-3 kinase/Akt/ glycogen synthase kinase 3β pathway activation and inducible nitric oxide synthase inhibition. |
| Q39042187 | Neuroprotective effect of melatonin against ischemia is partially mediated by alpha-7 nicotinic receptor modulation and HO-1 overexpression |
| Q46601596 | Neuroprotective effect of the new thiadiazolidinone NP00111 against oxygen-glucose deprivation in rat hippocampal slices: implication of ERK1/2 and PPARgamma receptors |
| Q48329113 | Neuroprotective effects of E-PodoFavalin-15999 (Atremorine®). |
| Q38851642 | Neuroprotective mechanism of the novel melatonin derivative Neu-P11 in brain ischemia related models |
| Q39530798 | Neurotoxicity induced by dexamethasone in the human neuroblastoma SH-SY5Y cell line can be prevented by folic acid. |
| Q39515762 | Neurotoxicity induced by okadaic acid in the human neuroblastoma SH-SY5Y line can be differentially prevented by α7 and β2* nicotinic stimulation |
| Q44908231 | Neurotransmitters, calcium signalling and neuronal communication |
| Q39002084 | New 5-unsubstituted dihydropyridines with improved CaV1.3 selectivity as potential neuroprotective agents against ischemic injury |
| Q38950400 | New melatonin-cinnamate hybrids as multi-target drugs for neurodegenerative diseases: Nrf2-induction, antioxidant effect and neuroprotection. |
| Q58436324 | Nicotinic receptor activation by epibatidine induces heme oxygenase-1 and protects chromaffin cells against oxidative stress |
| Q38814647 | Novel Tacrine-Benzofuran Hybrids as Potent Multitarget-Directed Ligands for the Treatment of Alzheimer's Disease: Design, Synthesis, Biological Evaluation, and X-ray Crystallography |
| Q48258502 | Novel multitarget ligand ITH33/IQM9.21 provides neuroprotection in in vitro and in vivo models related to brain ischemia |
| Q48401352 | Novel tacrine-grafted Ugi adducts as multipotent anti-Alzheimer drugs: a synthetic renewal in tacrine-ferulic acid hybrids |
| Q38652602 | Nrf2-ARE pathway: An emerging target against oxidative stress and neuroinflammation in neurodegenerative diseases. |
| Q40061304 | Nrf2-mediated haeme oxygenase-1 up-regulation induced by cobalt protoporphyrin has antinociceptive effects against inflammatory pain in the formalin test in mice |
| Q60688901 | Participation of calbindin-D28K in nociception: results from calbindin-D28K knockout mice |
| Q47330519 | Podocytes are new cellular targets of haemoglobin-mediated renal damage. |
| Q38913180 | Positive allosteric modulation of alpha-7 nicotinic receptors promotes cell death by inducing Ca(2+) release from the endoplasmic reticulum |
| Q42874918 | Poststress treatment with PNU282987 can rescue SH-SY5Y cells undergoing apoptosis via α7 nicotinic receptors linked to a Jak2/Akt/HO-1 signaling pathway |
| Q104742929 | Protective Role of Nrf2 in Renal Disease |
| Q39181634 | Protective effect of creatine against 6-hydroxydopamine-induced cell death in human neuroblastoma SH-SY5Y cells: Involvement of intracellular signaling pathways. |
| Q64249983 | QuinoxalineTacrine QT78, a Cholinesterase Inhibitor as a Potential Ligand for Alzheimer's Disease Therapy |
| Q27000279 | Redox control of microglial function: molecular mechanisms and functional significance |
| Q51552162 | Regulation by L channels of Ca(2+)-evoked secretory responses in ouabain-treated chromaffin cells. |
| Q42126283 | Sensory Input-Dependent Changes in Glutamatergic Neurotransmission- Related Genes and Proteins in the Adult Rat Trigeminal Ganglion |
| Q92947743 | Serum Amyloid A1 as a Potential Intracranial and Extracranial Clinical Severity Biomarker in Traumatic Brain Injury |
| Q46937770 | Small synthetic hyaluronan disaccharides afford neuroprotection in brain ischemia-related models |
| Q48125798 | Subthreshold Concentrations of Melatonin and Galantamine Improves Pathological AD-Hallmarks in Hippocampal Organotypic Cultures |
| Q39694999 | Synergistic neuroprotective effect of combined low concentrations of galantamine and melatonin against oxidative stress in SH-SY5Y neuroblastoma cells |
| Q58010802 | Synthesis and biological assessment of diversely substituted furo[2,3-b]quinolin-4-amine and pyrrolo[2,3-b]quinolin-4-amine derivatives, as novel tacrine analogues |
| Q39688701 | Synthesis, inhibitory activity of cholinesterases, and neuroprotective profile of novel 1,8-naphthyridine derivatives |
| Q39299148 | Targeting Nrf2 in the Protection against Renal Disease. |
| Q48950857 | The Antioxidant Additive Approach for Alzheimer's Disease Therapy: New Ferulic (Lipoic) Acid Plus Melatonin Modified Tacrines as Cholinesterases Inhibitors, Direct Antioxidants, and Nuclear Factor (Erythroid-Derived 2)-Like 2 Activators |
| Q46120469 | The N-terminal tripeptide of insulin-like growth factor-I protects against beta-amyloid-induced somatostatin depletion by calcium and glycogen synthase kinase 3 beta modulation. |
| Q54656497 | The antinociceptive effects of AR-A014418, a selective inhibitor of glycogen synthase kinase-3 beta, in mice. |
| Q38940729 | The melatonin-N,N-dibenzyl(N-methyl)amine hybrid ITH91/IQM157 affords neuroprotection in an in vitro Alzheimer's model via hemo-oxygenase-1 induction |
| Q42964845 | The microglial α7-acetylcholine nicotinic receptor is a key element in promoting neuroprotection by inducing heme oxygenase-1 via nuclear factor erythroid-2-related factor 2. |
Search more.